27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
The Firm is actively filing Mirena IUD lawsuits in a consolidated litigation that is continuing to mount in New Jersey's Bergen County Superior Court.
(PRWEB) January 25, 2015
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
More than 1,600 Mirena lawsuits (http://www.mirenalawsuit2014.com/ ) that allege similar complications of the IUD are now pending in a consolidated litigation underway in New Jersey, Bernstein Liebhard LLP reports.
According to a Case List posted on January 13th, 1,624 claims have now been filed over the birth control device in Bergen County Superior Court. Among other things, plaintiffs involved in these Mirena lawsuits allege Bayer Healthcare Pharmaceuticals' failure to adequately warn about complications that may follow implantation of the IUD. The litigation's update in January is the latest to depict its continued progress. (In Re: Mirena Litigation; Case No. 297)
“We continue to monitor the progress in New Jersey's Mirena IUD litigation, as our Firm continues to file lawsuits on behalf of women who were allegedly harmed by the birth control implant,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to women who allegedly sustained serious complications of the IUD.
Mirena Lawsuits
The Mirena IUD was approved in 2000 as a contraceptive, and has continued to rise in popularity since then. According to a marketing brochure distributed by Bayer Healthcare Pharmaceuticals, the IUD is now used by more than 2 million women nationwide as a means of preventing pregnancy, and also for the treatment of heavy menstrual bleeding.*
Mirena was approved for this use in 2009 by the U.S. Food and Drug Administration (FDA). That same year, Bayer came under fire for its promotion of the IUD in an FDA Warning Letter that took issue with certain misleading marketing claims that told women they would “look and feel great” using Mirena, and see improvement in their sex lives.**
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Mirena lawsuits now pending in New Jersey's Bergen County litigation allege that Bayer has a history of overstating its benefits and downplaying the risk for complications resulting from spontaneous migration of the IUD. According to claims, these injuries may include but are not limited to: uterine perforations, ectopic pregnancies, organ damage and infertility, which similarly occurred after proper insertion by a healthcare provider. Mirena lawsuits point out that current labeling on the IUD only indicates that migration may result when the uterus is perforated during insertion.
Similar claims have also been filed at the federal level in a multidistrict litigation (MDL) established in the U.S. District Court, Southern District of New York. There, court documents updated in January show 1,160 Mirena lawsuit filings now centralized for pretrial proceedings. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
Women who were allegedly harmed by the Mirena IUD may be eligible to pursue their own cases against Bayer. To learn more about filing a Mirena IUD lawsuit, please visit Bernstein Liebhard LLP's website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.
*http://www.mirena-us.com/assets/Mirena-Brochure_English.pdf, Bayer Healthcare Pharmaceuticals, 2011.
**http://www.fda.gov/newsevents/newsroom/pressannouncements/2009/ucm184747.htm, FDA, October 2009
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.mirenalawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author
For the original version on PRWeb visit: http://www.prweb.com/releases/mirena-lawsuit/mirena-iud/prweb12468223.htm
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.